These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16026789)

  • 21. Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
    Harangi M; Mirdamadi HZ; Seres I; Sztanek F; Molnár M; Kassai A; Derdák Z; Illyés L; Paragh G
    Transl Res; 2009 Apr; 153(4):190-8. PubMed ID: 19304278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between paraoxonase 1 activity and high density lipoprotein concentration during naturally occurring babesiosis in dogs.
    Rossi G; Kuleš J; Rafaj RB; Mrljak V; Lauzi S; Giordano A; Paltrinieri S
    Res Vet Sci; 2014 Oct; 97(2):318-24. PubMed ID: 25104322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation.
    Krzystek-Korpacka M; Boehm D; Matusiewicz M; Diakowska D; Grabowski K; Gamian A
    Clin Biochem; 2008 Jul; 41(10-11):804-11. PubMed ID: 18423402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.
    Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM
    Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma paraoxonase 1 arylesterase activity in D-galactose-induced aged rat model: correlation with LDL oxidation and redox status.
    Kumar D; Rizvi SI
    Aging Clin Exp Res; 2014 Jun; 26(3):261-7. PubMed ID: 24214524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
    Sardo MA; Campo S; Bonaiuto M; Bonaiuto A; Saitta C; Trimarchi G; Castaldo M; Bitto A; Cinquegrani M; Saitta A
    Curr Med Res Opin; 2005 May; 21(5):777-84. PubMed ID: 15969877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity.
    Gaidukov L; Tawfik DS
    J Lipid Res; 2007 Jul; 48(7):1637-46. PubMed ID: 17435182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of oxygen derived free radicals producer (xanthine oxidase) and scavenger (paraoxonase1) enzymes and lipid parameters in different cancer patients.
    Samra ZQ; Pervaiz S; Shaheen S; Dar N; Athar MA
    Clin Lab; 2011; 57(9-10):741-7. PubMed ID: 22029190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
    Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
    Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.
    Mackness B; Quarck R; Verreth W; Mackness M; Holvoet P
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1545-50. PubMed ID: 16627808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes.
    Mastorikou M; Mackness M; Mackness B
    Diabetes; 2006 Nov; 55(11):3099-103. PubMed ID: 17065348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women.
    Zago V; Sanguinetti S; Brites F; Berg G; Verona J; Basilio F; Wikinski R; Schreier L
    Atherosclerosis; 2004 Nov; 177(1):203-10. PubMed ID: 15488885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation.
    Nguyen SD; Sok DE
    Free Radic Res; 2004 Sep; 38(9):969-76. PubMed ID: 15621715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
    Rozenberg O; Aviram M
    Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
    Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
    Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.